EUZ Eckert & Ziegler Strahlen- und Medizintechnik AG

EQS-News: Eckert & Ziegler Ensures Business Continuity After Cyber-Attack

EQS-News: Eckert & Ziegler SE / Key word(s): Miscellaneous
Eckert & Ziegler Ensures Business Continuity After Cyber-Attack

25.02.2025 / 09:59 CET/CEST
The issuer is solely responsible for the content of this announcement.


Berlin, 25 February 2025. Following a cyber-attack on the IT infrastructure of Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) at the beginning of February, the Group's business operations can continue in most areas. In a few cases, there are still restrictions due to the gradual restoration at one point or another. 

As of this week, all essential core systems are back in operation. In some cases, temporary solutions have been implemented to offer all business partners the full range of services again.

"We have temporarily converted some digital processes to manual processes in recent weeks. However, our production continues, and we can supply our customers,” explained Dr. Harald Hasselmann, CEO of Eckert & Ziegler SE. 

Eckert & Ziegler remains committed to upholding the highest standards of safety and integrity and thanks its patients, customers and partners for their patience and understanding during this incident.

“I would like to thank everyone involved for their tremendous efforts during the last few weeks. A special thanks goes to our colleagues in IT, who are giving their best to get us back up and running as quickly as possible. We kindly ask our business partners to continue to be understanding and patient if there are still temporary delays or restrictions in communication at the moment,” added Dr. Harald Hasselmann.

The Executive Board currently does not expect any significant adverse effects on the business.

Contact:
Eckert & Ziegler SE
Karolin Riehle
Investor Relations
Robert-Rössle-Str. 10
13125 Berlin
Tel. -138
Tel.

 



25.02.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at -news.com


Language: English
Company: Eckert & Ziegler SE
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: 38
Fax:
Internet:
ISIN: DE0005659700
WKN: 565970
Indices: SDAX, TecDax,
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2091079

 
End of News EQS News Service

2091079  25.02.2025 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=2091079&application_name=news&site_id=research_pool~~~9efe1c65-8ece-4ff7-9608-f21c8e0a38a3
EN
25/02/2025

Underlying

Reports on Eckert & Ziegler Strahlen- und Medizintechnik AG

 PRESS RELEASE

EQS-News: Eckert & Ziegler: Record year 2024 with new all-time highs

EQS-News: Eckert & Ziegler SE / Key word(s): Annual Results/Forecast Eckert & Ziegler: Record year 2024 with new all-time highs 27.03.2025 / 07:45 CET/CEST The issuer is solely responsible for the content of this announcement. Berlin, 27 March 2025. Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) achieved a new record in the 2024 financial year with sales of € 295.8 million based on the preliminary annual financial statements*. Compared to the previous year, sales increased by almost € 50 million (+20%). EBIT before special items from continuing operations (adjusted EBIT)...

 PRESS RELEASE

EQS-News: Eckert & Ziegler: Rekordjahr 2024 mit neuen Höchstmarken

EQS-News: Eckert & Ziegler SE / Schlagwort(e): Jahresergebnis/Prognose Eckert & Ziegler: Rekordjahr 2024 mit neuen Höchstmarken 27.03.2025 / 07:45 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Berlin, den 27. März 2025. Die Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) erreichte auf Basis des vorläufigen Jahresabschlusses* im Geschäftsjahr 2024 mit einem Umsatz von 295,8 Mio. € eine neue Rekordmarke. Im Vergleich zum Vorjahr stieg der Umsatz um knapp 50 Mio. € (+20%). Das EBIT vor Sondereinflüssen aus fortgeführten Geschäftsbereic...

 PRESS RELEASE

EQS-News: Eckert & Ziegler to Supply Actinium Pharmaceuticals with Ac-...

EQS-News: Eckert & Ziegler SE / Key word(s): Agreement/Incoming Orders Eckert & Ziegler to Supply Actinium Pharmaceuticals with Ac-225 for Comprehensive Development Activities 25.03.2025 / 09:30 CET/CEST The issuer is solely responsible for the content of this announcement. Berlin, DE & New York, USA, 25 March 2025. Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) and Actinium Pharmaceuticals, Inc. announced that they have entered into an agreement for the supply of Actinium-225 (Ac-225). With this agreement, Actinium Pharmaceuticals will have access to Eckert & Ziegler’s ...

 PRESS RELEASE

EQS-News: Eckert & Ziegler beliefert Actinium Pharmaceuticals mit Ac-2...

EQS-News: Eckert & Ziegler SE / Schlagwort(e): Vereinbarung/Auftragseingänge Eckert & Ziegler beliefert Actinium Pharmaceuticals mit Ac-225 für umfangreiches Entwicklungsprogramm 25.03.2025 / 09:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Berlin, DE & New York, USA, 25. März 2025. Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) und Actinium Pharmaceuticals, Inc. gaben bekannt, dass sie eine Vereinbarung über die Lieferung von Actinium-225 (Ac-225) geschlossen haben. Mit dieser Vereinbarung erhält Actinium Pharmaceuticals Zugang...

 PRESS RELEASE

EQS-News: Eckert & Ziegler und AtomVie Global Radiopharma unterzeichne...

EQS-News: Eckert & Ziegler SE / Schlagwort(e): Auftragseingänge/Vereinbarung Eckert & Ziegler und AtomVie Global Radiopharma unterzeichnen weltweite Vereinbarung über die Lieferung von Lutetium-177 20.03.2025 / 14:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Berlin, DE & Hamilton, ON, CA, 20. März 2025. Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) und AtomVie Global Radiopharma Inc. (AtomVie) haben heute eine globale Liefervereinbarung bekannt gegeben. Eckert & Ziegler wird sein trägerfreies, qualitativ hochwertiges Lutetium-...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch